Searched for
BLOCK REVENUE GROWTH
OpenAI joins rival Anthropic in race to Wall StreetOpenAI did not disclose the size or terms of the offering, and said a timeline has not yet been determined. "It may be a while because ther...- Meet Zach Yadegari: US teen founder sold gaming app for $100K, then built $40M Cal AI and now he is going with the 'Flow'Zach Yadegari, based in Miami, achieved two successful startup exits before age 20, selling a gaming site for $100,000 and an AI calorie tr...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- OpenAI files for US IPO after Anthropic as AI giants head to public marketsAI giant OpenAI has confidentially filed for a US initial public offering. This move follows rival Anthropic's similar filing. Investors ar...
- OpenAI IPO: ChatGPT maker files for US Stock Market initial public offering after Anthropic, SpaceXOpenAI would set the stage for a trio of trillion-dollar-valuation companies debuting rapidly, which together are seen as the most conseque...
- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- The appraisal hangover: How a poor performance review can hurt your career if you react emotionallyCold data, not emotions, will cure your appraisal hangover, says Devashish Chakravarty.
- Two Adani Group stocks in focus as GQG sells stake in Rs 5,750 crore deal; SBI MF lone buyerAdani Enterprises and Adani Energy Solutions will be in focus after GQG Partners sold stakes worth about Rs 5,750 crore via block deals, wi...
- ‘Main Street vs The Merger’: Hollywood workers rally against $110 bn Paramount-Warner dealA major media merger faces opposition from industry professionals and politicians. They fear the Paramount Skydance acquisition of Warner B...
- Go Digit Insurance shares jump 9% after Rs 100 crore block deal attracts MFs, global investorGo Digit General Insurance shares saw a significant jump. This surge followed a Rs 100-crore block deal. Aditya Birla Sun Life Mutual Fund ...
- Groww shares gain 3% as Goldman Sachs buys stake in Rs 210-crore block dealBillionbrain Garage Ventures, parent of Groww, saw its shares rally 3% after Goldman Sachs acquired over 1.13 crore shares for Rs 210.43 cr...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- ET Prime Special Series: Multibagger or IBC - Curious case of one stock, two companies. Only one of them makes brakesOn paper this is a friction-material company. In practice, the larger force inside the company is an investment portfolio. The friction bus...
- US Fed says Iran war driving 'moderate-to-strong' inflationUS inflation rose at a moderate to strong pace, driven largely by surging energy costs linked to the Iran war, the Federal Reserve said. Hi...
- Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...
- India meets FY26 fiscal deficit target of 4.4% of GDP; revenue deficit at 1.55%India's fiscal deficit reached the budgeted 4.4% of GDP for fiscal 2026. This eases immediate government finance worries. However, the focu...
- Stocks in news: IndiGo, Suzlon Energy, Patanjali Foods, PB Fintech, VedantaMarkets experienced significant volatility on Friday, with indices falling in the final hour due to heavy institutional selling. Several co...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
Load More
